Used in pharmaceutical research as a potent inhibitor of specific kinase enzymes involved in cancer cell proliferation. Shows promise in targeted therapies for solid tumors, particularly in breast and lung cancers. Its structure enables high selectivity for mutant forms of epidermal growth factor receptor (EGFR), making it valuable in overcoming drug resistance. Also investigated for anti-inflammatory applications due to modulation of signaling pathways linked to chronic inflammation. Currently in preclinical development stages, serving as a lead compound for optimizing bioavailability and reducing off-target effects.